Localized Castleman's disease associated with systemic AA amyloidosis. Regression of amyloid deposits after tumor removal [1]

Annals of Hematology

Volumn 86, Issue 1, 2007, Pages 55-57

  Androulaki, A ^a   Giaslakiotis, K ^a   Giakoumi, X ^a   Aessopos, A ^a   Lazaris, A C ^b  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CONTRAST MEDIUM; IRON;

ADULT; AMYLOIDOSIS; ANAMNESIS; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; FATIGUE; FEMALE; FEVER; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION TEST; LABORATORY TEST; LETTER; LIVER BIOPSY; LYMPHADENECTOMY; MALAISE; MICROCYTIC ANEMIA; PATIENT REFERRAL; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SPLENOMEGALY; SURGICAL TECHNIQUE; TISSUE DISTRIBUTION; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR REGRESSION; TUMOR VOLUME;

AMYLOIDOSIS; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HUMANS; MIDDLE AGED; SENILE PLAQUES;

EID: 33846427309     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-006-0187-0     Document Type: Letter

References (11)

1. Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9:822-830
2. Frizzera G, Peterson BA, Bayrd ED, Goldman A (1985) A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: Clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3:1202-1216
3. Lachmann HJ, Gilbertson JA, Gillmore JD, Hawkins PN, Pepys MB (2002) Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease. QJM 95: 211-218
4. Altiparmak MR, Pamuk GE, Pamuk ON, Dogusoy G (2002) Secondary amyloidosis in Castleman's disease: Review of the literature and report of a case. Ann Hematol 81:336-339
5. Derici U, Arinsoy T, Ataoglu O, Bali M, Eroglu A, Goker B, Sindel S (2002) Localized Castleman's disease and nephrotic syndrome not responsive to resection plus colchicine therapy. Ann Hematol 81:399-401
6. Mandreoli M, Casanova S, Vianelli N, Pasquali S, Zucchelli P (2002) Remission of nephrotic syndrome due to AA amyloidosis and initiation of glomerular repair after surgical resection of localized Castleman's disease. Nephron 90:336-340
7. Gholam D, Vantelon JM, Al-Jijakli A, Bourhis JH (2003) A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody. Ann Hematol 82:766-768
8. Leung KT, Wong KM, Choi KS, Chau KF, Li CS (2004) Multicentric Castleman's disease complicated by secondary renal amyloidosis. Nephrology (Carlton) 9:392-393
9. Verbrugghe W, Maes BD, Knockaert DC (2005) Localised plasma-cell type Castleman's disease and AA-amyloidosis cured by resection. A case report and review of the literature. Acta Clin Belg 60:22-27
10. Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T et al (1989) Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74:1360-1367
11. Nishimoto N, Sasai M, Shima Y, Nakagawa M, Matsumoto T, Shirai T, Kishimoto T, Yoshizaki K (2000) Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 95:56-61